EN
HI
Parmax Pharma Share Price
PARMAX
135.10.00 (0.00%)
Last updated on 16 Nov, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 17 Nov, 2026, Parmax Pharma stock price is ₹135.1. During the trading session, the stock has moved between an intraday low of ₹135.00 and an intraday high of ₹136.35. Over the last 52 weeks, Parmax Pharma has traded between ₹22.60 and ₹139.10.
The stock has recorded a trading volume of 5,334 shares,. Its Average Traded Price (ATP) is ₹135.68, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹135.10.
Parmax Pharma has an upper circuit limit of ₹136.45 and a lower circuit limit of ₹133.75. The total value traded stands at ₹7.24 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Parmax Pharma also offers a dividend yield of 0%.
Parmax Pharma Share Price Chart
Parmax Pharma Share Key Metrics
Volume
5334.00
Market Cap
92.93 CR
LTQ@LTP
5@135.10
ATP
135.68
Var Margin
0 %
Circuit Range
133.75-136.45
Delivery %
100 %
Value
7.24 L
ASM/GSM
No
Market Lot
1
Parmax Pharma Resistance and Support
Pivot 135.48
Resistance
First Resistance
135.96
Second Resistance
136.83
Third Resistance
137.31
Support
First Support
134.61
Second Support
134.13
Third Support
133.26
Parmax Pharma Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
30.8%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
69.2%
Others
0%
Total Promoters
MAR '24
30.83%
JUN '24
30.8%
SEP '24
30.8%
DEC '24
30.8%
Parmax Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-14 | Quarterly Results |
| 2026-11-13 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-06-08 | Fund raising |
| 2026-06-02 | Audited Results |
| 2026-05-30 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Parmax Pharma News
Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Approved The Agenda As Per The Attached Intimation
Parmax Pharma's board adjourned its Q2 FY26 financial results but approved shifting the registered office from Gujarat to Maharashtra. The board also enhanced borrowing and asset mortgage limits to ₹50 crores each and approved a variation in the utilization of preferential issue proceeds.
Nov 14 2026 21:44:50
Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Review And Approval Of Financial Results For Quarter And Half Year Ended September 30, 2026
Parmax Pharma board will meet on November 13, 2026, for financial results. The agenda also includes evaluating a proposal to shift the registered office of the company.
Nov 10 2026 19:44:07
Parmax Pharma Management
| Name | Position |
|---|---|
| Umang A Gosalia | Managing Director |
| Nikhil Uchat | Non Executive Independent Director |
Parmax Pharma Similar Stocks
Beryl Drugs Ltd.
25.72
1.13 (4.60%)
Sharma East India Hospitals & Medical Research Ltd
81.00
-3.25 (3.86%)
Norris Medicines Ltd.
14.80
0.70 (4.96%)
Soni Medicare Ltd.
65.87
-0.13 (0.20%)
Colinz Laboratories Ltd.
67.50
0.00 (0.00%)
Broach Lifecare Hospital Ltd.
12.70
0.00 (0.00%)
Starsource Multitrade Ltd.
88.00
-3.75 (4.09%)
Unjha Formulations Ltd.
27.25
-0.62 (2.22%)
Parmax Pharma FAQs
The Buying Price of Parmax Pharma share is 135.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Parmax Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Parmax Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 40.35 & 2.39 with sector averages, along with growth rates and financial metrics.
The Market Cap of Parmax Pharma is 92.93 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Parmax Pharma share price is 139.10 & 22.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Parmax Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in PARMAX
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC